Back
BioXcel Therapeutics, Inc. Vs. Okta, Inc. Industry Stock Comparison
Sell
21
BTAI
BioXcel Therapeutics, Inc.
Last Price:
$1.56
Seasonality Move:
59.54%
Sell
47
OKTA
Okta, Inc.
Last Price:
$88.10
Seasonality Move:
15.75%
Sell
21
BioXcel Therapeutics, Inc. (BTAI)
is a Sell
Is BioXcel Therapeutics, Inc. a Buy, Sell or Hold?
-
The current BioXcel Therapeutics, Inc. [BTAI] share price is $1.66. The Score for BTAI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Okta, Inc. (OKTA)
is a Sell
Is Okta, Inc. a Buy, Sell or Hold?
-
The current Okta, Inc. [OKTA] share price is $88.61. The Score for OKTA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
OKTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BTAI Stock Price Chart
What is BioXcel Therapeutics, Inc.'s stock price today?
-
The BioXcel Therapeutics, Inc. share price today is $1.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
OKTA Stock Price Chart
What is Okta, Inc.'s stock price today?
-
The Okta, Inc. share price today is $88.61The current trend is moderately bearish and OKTA is experiencing slight buying pressure.
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 37 | Sell |
| Chaikin Money Flow: | -152827 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.77 - 2.11) | Sell |
| Bollinger Bands (100): | (1.66 - 4) | Sell |
OKTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 53.82 | Buy |
| Chaikin Money Flow: | 363908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.67 - 90.27) | Buy |
| Bollinger Bands (100): | (85.01 - 92.83) | Sell |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.78 | Sell |
| 20-day SMA: | 1.96 | Sell |
| 50-day SMA: | 1.99 | Sell |
| 200-day SMA: | 2.31 | Sell |
| 8-day EMA: | 1.78 | Sell |
| 20-day EMA: | 1.88 | Sell |
| 50-day EMA: | 2.08 | Sell |
| 200-day EMA: | 4.45 | Sell |
OKTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.56 | Sell |
| 20-day SMA: | 87.57 | Buy |
| 50-day SMA: | 86.31 | Buy |
| 200-day SMA: | 96.9 | Sell |
| 8-day EMA: | 89.08 | Sell |
| 20-day EMA: | 87.9 | Buy |
| 50-day EMA: | 87.51 | Buy |
| 200-day EMA: | 91.73 | Sell |
BioXcel Therapeutics, Inc. Earnings Growth & BTAI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.54 per share, and an increase next year of $3.74 per share.
Okta, Inc. Earnings Growth & OKTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.07 per share, an increase this year of $1.29 per share, and an increase next year of $0.66 per share.
BioXcel Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Okta, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||